274
Participants
Start Date
July 19, 2021
Primary Completion Date
February 17, 2022
Study Completion Date
March 4, 2022
VX-548
Tablets for oral administration.
HB/APAP
Capsules for oral administration.
Placebo (matched to VX-548)
Placebo matched to VX-548 for oral administration.
Placebo (matched to HB/APAP)
Placebo matched to HB/APAP for oral administration.
Chesapeake Research Group, Pasadena
Atlanta Center for Medical Research, Atlanta
Shoals Medical Trials Inc., Sheffield
Midwest Clinical Research Center, Dayton
Legent Orthopedic Hospital, Carrollton
First Surgical Hospital, Bellaire
Endeavor Clinical Trials, San Antonio
JBR Clinical Research, Salt Lake City
Arizona Research Center, Phoenix
Lotus Clinical Research, Pasadena
New Hope Research Development, Tarzana
Anaheim Clinical Trials, Anaheim
Vertex Pharmaceuticals Incorporated
INDUSTRY